Is Freeport-McMoRan Inc. (FCX) overvalued or undervalued?
Updated Nov 10, 2026 · researched from SEC filings · educational, not advice
At a recent price of $62.33, Freeport-McMoRan Inc. (FCX) sits inside a range too wide to call either way: our valuation lenses put the business somewhere between $27.08 and $99.47 per share. They disagree too widely for us to state a single fair value. We publish the range rather than a midpoint because a number that precise would claim more than the methods can support. This is an educational model, not a price target or a recommendation.
The valuation discounts Freeport-McMoRan Inc.'s projected free cash flows at a weighted-average cost of capital (WACC) of 10.7%, with a long-run terminal growth rate of 2.5%. About 69% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.
Running the DCF in reverse — solving for the growth the current price already assumes — the market is implying roughly 16.8% annual revenue growth for FCX. Our base case instead compounds to about 5.1% a year over the same forecast, so the market is pricing in materially faster growth than our base case. The reverse-DCF is a quick sanity check: it reframes 'is this stock cheap?' as 'do I believe the growth the price requires?' rather than arguing over a single point estimate of fair value.
Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, FCX's modeled DCF value ranges from about $27.37 to $51.63 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.
How to read this page: the DCF fair value is what Freeport-McMoRan Inc. would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of FCX's intrinsic value. Figures update as new filings and prices come in.
The assumptions behind FCX's DCF
| Input | Value | Source |
|---|---|---|
| Base-year revenue | $25,186,000,000 | Freeport-McMoRan Inc. FY2025 10-K (accession 0000831259-26-000012): us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, FY2025 full year. |
| Base EBIT margin | 25.9% | Freeport-McMoRan Inc. FY2025 10-K (accession 0000831259-26-000012): us-gaap:OperatingIncomeLoss 6,518,000,000 / revenue 25,186,000,000 = 25.88%, FY2025. |
| Forecast revenue growth | 6% → 6% → 5% → 5% → 4% | Assumption — TickerWorth's 5-year explicit forecast |
| Risk-free rate | 4.9% | Live feed — US 10-year Treasury yield (^TNX) |
| Beta | 1.37 | Live feed — yfinance, 5-year monthly beta vs the S&P 500 (clamped to 0.4–2.5) |
| Terminal growth | 2.5% | Assumption — TickerWorth house default 2.5%, held below WACC |
| Diluted shares | 1,443M | Freeport-McMoRan Inc. FY2025 10-K (accession 0000831259-26-000012): WeightedAverageNumberOfDilutedSharesOutstanding = 1,443,000,000 shares, FY2025. |
| Market price | $62.33 | Delayed quote · as of 2026-11-10 05:04 UTC |
Researched from filings: the base year — revenue, operating margin and balance-sheet figures — comes straight from this company's latest SEC 10-K (cached, refreshed periodically). Forward growth and terminal value are still algorithmic estimates; drag the WACC slider to test sensitivity.
Explore more
Most undervalued stocks (per our valuation) · All valued stocks · Interactive FCX valuation & downloadable modelEducational tool. Every output reflects the assumptions shown — not a prediction and not investment advice. TickerWorth is an educational DCF tool, not a licensed investment adviser. Figures are estimates derived from public filings and market data and can be wrong.